ClearPoint Neuro, Inc. (CLPT) Stock Forecast
CLPT analyst forecast
as of October 18, 2026- Analyst consensus
- Strong buy 5.00 / 5 from 2 analysts
- Price target
- $23.50 average of analyst targets
- Upside to target
- +159.1% from the latest close
- Next earnings
- October 28, 2026 EPS estimate $-0.27
- 52-week range
- $8.66 – $27.32
CLPT analyst ratings
2 analystsNumber of analysts at each rating.
CLPT price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
CLPT earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$0.32 | −$0.36 | −$0.27 | −$0.21 | −50.0% | 2 |
| Current fiscal year (2026) | −$1.30 | −$1.39 | −$1.22 | −$0.90 | −45.0% | 2 |
| Next fiscal year (2027) | −$1.20 | −$1.23 | −$1.16 | −$1.30 | +8.4% | 2 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
CLPT revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $12.3M | $12.1M | $12.5M | +38.8% | 2 |
| Current fiscal year (2026) | $49.0M | $48.0M | $50.0M | +32.5% | 2 |
| Next fiscal year (2027) | $56.5M | $56.0M | $57.1M | +15.4% | 2 |
CLPT EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
CLPT revenue: reported and forecast
CLPT EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$0.26 | −$0.26 | −$0.32 | −$0.32 | −$0.32 | +19.6% | 0 up · 3 down |
| Current fiscal year (2026) | −$1.11 | −$1.11 | −$1.30 | −$1.30 | −$1.30 | +17.2% | 0 up · 3 down |
| Next fiscal year (2027) | −$0.94 | −$0.94 | −$1.20 | −$1.20 | −$1.20 | +27.1% | 0 up · 3 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
CLPT earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; CLPT beat in 4 of 12.
What analysts expect from CLPT
2 analysts cover ClearPoint Neuro; their consensus rating is strong buy (5.00 on a 1–5 scale, where 5 is a strong buy). The average price target is $23.50, 159.1% above the latest close of $9.07. Analysts expect earnings of −$1.30 per share for 2026, −45.0% from a year earlier. For 2027 the average estimate is −$1.20 per share on revenue of $56.5 million. ClearPoint Neuro beat the EPS estimate in 4 of the last 12 quarters.
Related: CLPT income statement, CLPT key metrics, CLPT chart. See the CLPT stock overview for the latest quote and news.
CLPT forecast FAQ
What is ClearPoint Neuro's price target?
The average analyst price target for ClearPoint Neuro is $23.50, 159.1% above the latest close of $9.07.
Is ClearPoint Neuro a buy, hold or sell?
Of 2 analysts covering ClearPoint Neuro, 2 rate it a strong buy, 0 a buy, 0 a hold, 0 a sell and 0 a strong sell, a consensus of strong buy. Ratings are opinions, not a recommendation from Quotelinks.
What is ClearPoint Neuro's EPS forecast?
Analysts forecast −$1.30 per share for 2026 (range −$1.39 to −$1.22); for 2027 the estimate is −$1.20.
What is ClearPoint Neuro's revenue forecast?
The average revenue estimate for 2026 is $49.0 million, growth of 32.5%; for 2027 it is $56.5 million.
When does ClearPoint Neuro report earnings?
ClearPoint Neuro is expected to report results for the quarter ending September 30, 2026 on October 28, 2026 after the market closes; the EPS estimate is $-0.27.
Does ClearPoint Neuro usually beat earnings estimates?
ClearPoint Neuro reported EPS at or above the analyst estimate in 4 of the last 12 quarters.